In order to better serve our audience, we're shifting our social media focus to other platforms. Find us on LinkedIn, BlueSky, and YouTube for more pharma news and analysis, or click here: pharmaphorum.com/register to subscribe to our email newsletter.

Deep Dive: How past #vaccines discoveries shaped today’s healthcare landscape. Check out the full feature here: pharmaphorum.com/deep-dive/h… #MedicalResearch #PharmaInsights

In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients. pharmaphorum.com/digital/sma…

If you missed, it take a look back at the final edition of #ChangingFaces for #2024. pharmaphorum.com/rd/changing…

The promise of #AI in #biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties. pharmaphorum.com/digital/bio…

The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability. pharmaphorum.com/patients/ta…

With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth. pharmaphorum.com/patients/fo…

If you missed, it take a look back at the final edition of #ChangingFaces for #2024. pharmaphorum.com/rd/changing…

Why is rare disease treatment so challenging? And how can cell & gene therapies help? Join @IPGHealth for a webinar on 5th March to find out. Register here: bit.ly/3Cpx0hC #raredisease #ppwebinar

In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients. pharmaphorum.com/digital/sma…

Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves. pharmaphorum.com/patients/ca…

With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth. pharmaphorum.com/patients/fo…

The promise of #AI in #biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties. pharmaphorum.com/digital/bio…

In 2025, as #biopharma companies embrace #AI-first, purpose-built solution #strategies to better serve #healthcareprofessionals and #patients. pharmaphorum.com/digital/sma…

If you missed, it take a look back at the final edition of #ChangingFaces for #2024. pharmaphorum.com/rd/changing…

The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability. pharmaphorum.com/patients/ta…

Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves. pharmaphorum.com/patients/ca…

The misuse of #prescriptionmedications like #Wegovy and #Ozempic, compounded by a lack of stringent clinical procedures, underscores the urgent need for heightened accountability. pharmaphorum.com/patients/ta…

With the growing demand for #chronicdisease treatments and the #ageing baby boomer population, the #infusionmarket is set for significant growth. pharmaphorum.com/patients/fo…

Just as #HCPs tailor their approach and #communication to meet the unique needs of each #patient, #healthcare and #pharmabrands need to recognise and address the individual needs and preferences of providers themselves. pharmaphorum.com/patients/ca…